Search

everythinglearnresearchcommunity

for

Search:↓

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Hormonal therapies effectively treat acne and improve quality of life.

Compounds from Eclipta prostrata L. plant have diabetes and obesity-fighting properties and reduce inflammation.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Inflammation is a key factor in heart disease and targeting it can reduce heart problems.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Repurposing existing drugs and using micronutrients may effectively target cancer stem cells and improve cancer treatment.

TIP39 and PTH2R help control calcium levels and skin cell development.

Multitarget drugs are needed to better treat complex diseases.

Retinoids can help treat skin pigmentation disorders by affecting melanin production.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Cryptotanshinone may help treat postmenopausal osteoporosis and protect kidneys.

Balancing lipophilicity and solubility is key for effective and safe ketorolac prodrugs.

New molecules can prevent cell death in hair follicles.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.